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Influence of waist circumference on glucose metabolism evaluated with 
oral glucose tolerance test in a group of obese patients 
Disoteo Olga1, Pizzi Gianluigi2, Muratori Fabrizio1, Grossrubatscher 
Erika', Dalino Paolo', Oppizzi Giuseppe', Fossati Carlo', Loli Paola' 
'Niguarda Hospital - Endocrine Unit; 'Niguarda Hospital - Diabetologic 
Unit 
Aim of this study was to evaluate the relation between waist 
circumference (WC) and glucose metabolism in obese subjects. We 
evaluated 132 consecutive obese subjects (20 men and 112 women, 
median age 46 yr) for metabolic syndrome. The subjects underwent body 
mass index (BMI), WC and oral glucose tolerance test (OGTT) with 
determination of fasting insulin and plasma glucose (FPG) and plasma 
glucose at 120'. The cut off' for impaired gluCO!Ie tolerance (IGT) and 
diabetes was glucose at 120' > 140 mg/dL and > 200 mg/dL 
respectively. Homeostasi.s model assessment-insulin resistance (HOMA 
IR) was assessed. Correlation analyses were determined by calculating 
the Spearman's coefficient. A Stepwise multiple regression analysis was 
performed to determine which variables predicted FPG. The values 
recorded were BMI 37,1 Jq¥m' ± 5,38, WC 109,8 cm± 11,14, FPG 93,6 
mg/dL ± 15,05, 120' plasma glucose 115,6 mgfdL ± 44,02, basal insulin 
13,2 mUlL ± 5,10, HOMA-IR 3,12 ± 1,58. The prevalence of impaired 
fasting glucose (IFG) (FPG > 100 mg/dL) was of25,7% (34pts), of IGT 
was 18% (24 patients) and of DM was of 6% (8 patients). Linear 
correlation was significant between WC and FPG (r = 0,24 P=0,04 ), but 
not among WC and other variables. In multiple regression FPG was 
linked to fasting insulinem.ia (P 0,013) and WC (P 0,05). The present 
data supported that visceral obesity evaluates with WC is a risk factor for 
IFG. In contrast with previous reports, these data do not suggest a role 
for WC in IGT. 
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Tbc beta-adrenergic anlagollist propranolol partly abolishes thermogenic response 
ofbioactive food ingredients 
Bclza Anita', Gille Maj-Britt', John Smah', K.ondrup Jens' 
'Tbc Royal Veterinary And Agricultural University, Department OfHmnan 
Nutrition 
Bac:kgnnmd: A combination of tyrosine, capsaicin, catechines, and caffeine has 
been shown to possess a pronounced thermogenic effix:t in humans. 
Objective: To investigate whetber the thermogenic response to the bioactive 
combination (BC) could be dUnini3hed or abolished by propranolol. 
Design: Twenty-two men (BMI: 26.0±3.6 kg/m', mean:i:SD) participated in a 4-
way randomized, double>-blind, placebo-controlled crossover study. Tbe following 
4 treatments w= ll:sted: I. placebo; 2. BC; 3. BC + 5 mg propranolol; 4. BC+ 10 
mg propranolol. Resting metabolic mte (RMR.), respiratory quotient, and the 
thermogenic response w= measured for 5 hoUI!J post-inlake, whilst systolic and 
diastolic blood presiiUle (SBP ami DBP, respectively), heart rate (HR) ami appetite 
ratings w= assessed. 
Raultl: BC increased RMR by S% (73 (36;110) kJ/5-h (mean (95%CI), 
P<O.OOOl) compared to placebo. Both propranolol doses blunted the thermogenic 
response by SO% compared to placebo (P<O.Ol). Propranolol (5 or 10 mg) reduced 
fat Ollidstion by S% (~.001) and by 7% (~.0002) compared to placebo, 
respectively. BC increaaed SBP by 3% (4±1.0 mmHg, ~.003) compared to 
placebo. Tbc effect of BC on SBP was reduced by 25% by propranolol (P-0.07). 
BC (with or without propranolol) increased DBP by 6% (4±1 mmHg, P-0.0002). 
Propranolol decreased HR by 5% (3H bpm (P<O.OOOl)) compared to placebo ami 
BC. No effects w= observed on appetite ratings. 
Conclu1lon: Tbc study confirms the thermogenic properties of BC. The SO"A> 
reduction crf the thermogenic response by propranolol indicates that beta-adrenergic 
pathways are partly responsible fur the thermogenic response. 
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Morphologic and systemic alterations in obese and overweight subjects 
after a physical activity intervention program 
M3ialhaes Pedro1, Costa Maria1, Lopes Vitor', Duarte Jose2 
'B~ Polytechnic Institute; 'Faculty of Sport - Oporto University 
There are some evidences that exercise training reduces total and 
abdominal fat and some systemic variables with improve health benefits. 
The aim of this study was to analyse the variation of some morphologic 
and systemic variables in 16 (age=64.5±7.2) obese and overweight 
(BMI=31.4±5.7) type 2 diabetic patients, of both gender, during a 
regular physical exercise program, which consists of 3 5 minutes of fast 
walking every days of the week, during 8 months, and no diet 
intervention. The change was analysed with MANOV A. In total 
cholesterol, LDL, HDL, TG and Insulin the changes were analysed in a 4 
months period and in weight, BMI, waist and blood pressure were 
analysed in an 8 montbs period. There was significant decreases on 
weight [F(l, 15) = 6.688; P = 0.021], BMI [F(l, 15) = 7.396; P = 0.016], 
waist [F(1, 15) = 43.032; P = 0.000] and LDL [F(1, 7) = 14,264; P = 
0.007]. It could be concluded that the participation in this physical 
activity program enables the subjects to improve their morphologic and 
systemic parameters without alterations in their diet. 
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Adipocyte fillty acid-binding protein - a biomarker asoociated with the mctsbolic 
syndrome and/or an indicator ofwei&ht chaDgc? 
Ebenbicb!cr Cbriotoph1, Engl Julia1, Ciaidi c::hmtian1, Tatan:zyk Tobias1, Xucr Su.sanne1, 
Laimer Mmiwl1, Weioo Helmut', Aigner Fnmz', Tilg Herbert', Paloch Jooef 
'Medical Uni\WSity Innsbruck, Department Of Intemal Medicine, Clinical Division Of 
General Internal Medicine; 'Dcpa:rtment of Surgety, Medical Univemity Innsbruck, 
A118tria; 'Depanmcnt of Medicine, Academic TeachiDg Hospital Hall, Austria 
~lllld: Adipocyte fillty-acid bindiDg protein (A-FABP) is a plasma bioma:rker 
=tJy astoeialed with tile metabolic syndiOme. Aim of these IIUdiee wu IQ investigate 
changes of A-FABP during profound weight looo induced by laparoocopic adjustable 
gastric bandj,g. 
Subjeda lllld metbodl: In stwly onc 29 severely obeoe female subject& wen: examined 
before ami one year after omgical !Imtment In stwly two paticmiB wen: investigated in 
three months intervala. Metabolic parameters were determined using standard methods 
and A-F ABP wu detected with a CO!IIIIlCrt:ially avsilable ELlS A. 
Roeulta: Mean weight looo after one year wu 24.9 kg (P<O.OOl), mainly due to a 
dec:rcs8c in fat mati8. Metabolic partiiiiCII:r8 improved oubsttmtially. However, serum 
AFABP remained stable. In study two tea patients we examined quarterly to dctemtinc 
tile time course of A-FABP changes. Quarterly measuremem of lerulll A-FABP were 
significantly higher than baseline levels with tbe highest A-FABP value after tbe first 
three month, wbere po.ticmiB had higbeot weight 101111. 
CDDdJU!ooa: In &WlliilBI)', OlD' reaulta in study one confum tbat A-F ABP oerum level a ore 
elevated in obeoe oubjecta and clooely liBIOCialed with obesity and the metabolic 
syndrome. However, one year after pronoUIIIled weight loss A-FABP levools rmWned 
unchaoged. In study two time coune aoalyJea revealed m.uimum inaease of serum 
AFABP in parallel to highest weight 101111. We conclude tbat A-FABP 1C1U1D levds are a 
bimnarki:r of metabolic oyndrome and additionslly m indicator of weight loao, 
demonstiating tbe current lipolytic adivity in adipose tissue. 
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